PLUROGEN THERAPEUTICS

plurogen-therapeutics-logo

PluroGen's core technology platform was developed by researchers and physicians in University of Virginia's (UVA) Plastic Surgery Research Laboratory beginning in the 1970's. Their co-founder, George T. Rodeheaver, Ph.D., is one of the inventors of this technology and has supervised the formulation and production at UVA of one of their first products for use on burn and chronic wound patients at the UVA Health System for the past fifteen years.

#SimilarOrganizations #People #Financial #Website #More

PLUROGEN THERAPEUTICS

Social Links:

Industry:
Health Care Manufacturing Medical Therapeutics

Founded:
2007-01-01

Address:
Charlottesville, Virginia, United States

Country:
United States

Website Url:
http://www.wardenbio.com

Total Employee:
11+

Status:
Active

Contact:
443-994-0101

Email Addresses:
[email protected]

Total Funding:
4.65 M USD

Technology used in webpage:
CrUX Dataset CrUX Top 50m GoDaddy SSL


Similar Organizations

cabaletta-bio-logo

Cabaletta Bio

Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.

lannett-company-logo

Lannett Company

Lannett develops, manufactures, and distributes generic prescription pharmaceutical products in tablet.

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

theraplant-logo

Theraplant

Theraplant is a licensed Medical Marijuana Produce.

verismo-therapeutics-logo

Verismo Therapeutics

Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.


Current Advisors List

james-farinholt_image

James Farinholt Senior Financial Advisor, Treasurer & Board of Directors @ PluroGen Therapeutics
Advisor

george-rodeheaver_image

George Rodeheaver Chairman of the Board of Directors @ PluroGen Therapeutics
Board_member

daniel-brody_image

Daniel Brody Board of Directors @ PluroGen Therapeutics
Board_member

Current Employees Featured

glenn-warden_image

Glenn Warden
Glenn Warden Chief Medical Officer @ PluroGen Therapeutics
Chief Medical Officer

george-rodeheaver_image

George Rodeheaver
George Rodeheaver Co-Founder @ PluroGen Therapeutics
Co-Founder

Founder


adam-katz_image

Adam Katz

george-rodeheaver_image

George Rodeheaver

Investors List

keiretsu-forum_image

Keiretsu Forum

Keiretsu Forum investment in Angel Round - PluroGen Therapeutics

jefferson-corner-group_image

Jefferson Corner Group

Jefferson Corner Group investment in Seed Round - PluroGen Therapeutics

virginia-active-angel-network_image

Virginia Active Angel Network

Virginia Active Angel Network investment in Seed Round - PluroGen Therapeutics

cato-bioventures_image

Cato BioVentures

Cato BioVentures investment in Seed Round - PluroGen Therapeutics

Official Site Inspections

http://www.wardenbio.com Semrush global rank: 13.45 M Semrush visits lastest month: 78

  • Host name: a2e6b661ca0e4c4c4.awsglobalaccelerator.com
  • IP address: 99.83.175.80
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "PluroGen Therapeutics"

Warden Bio 2025 Company Profile: Valuation, Investors

Warden Bio was founded in 2021. Where is Warden Bio headquartered? Warden Bio is headquartered in Durham, NC. What industry is Warden Bio in? Warden Bioโ€™s primary industry โ€ฆSee details»

Warden Bio - Products, Competitors, Financials, Employees, โ€ฆ

With the acquisition, Warden Bio co-founder Kunal Kishnani joined Kriya as president of its rare disease division, where he will lead overall strategic, development, and partnership activities, โ€ฆSee details»

www.wardenbio.com

Www.wardenbio.comSee details»

Kriya Expands Gene Therapy Pipeline and Establishes its Rare โ€ฆ

Portfolio includes five investigational gene therapy programs for glycogen storage disorders that have no existing FDA-approved treatments available Warden Bio Co-Founder Kunal Kishnani โ€ฆSee details»

Warden Bio - Duke OTC

Warden Bio is developing novel AAV-mediated gene therapies for glycogen storage disorders (GSDs). The GSD gene therapy is based on research led by the lab of Dr. Priya Kishnani, โ€ฆSee details»

Kriya Acquires Warden Bio to Expand Gene Therapy Pipeline and โ€ฆ

Jan 7, 2022 The new GSD gene therapy programs Warden Bio brings to Kriya are based on research led by the lab of Priya Kishnani, Chen Family distinguished professor and division โ€ฆSee details»

WARDEN BIO INC Durham NC, 27713 - Company Profile - Cortera

Free Business profile for WARDEN BIO INC at 2530 Meridian Pkwy, Durham, NC, 27713-5273, US.See details»

Warden BioScience Associates LLC - Drug pipelines, Patents, โ€ฆ

Explore Warden BioScience Associates LLC with its drug pipeline, therapeutic area, technology platform, 1 literature.See details»

Warden Bio, Inc.: Drug pipelines, Patents, Clinical trials - Synapse

Jul 26, 2023 Explore Warden Bio, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»

MergerLinks - Kriya completed the acquisition of Warden Bio.

Jan 7, 2021 Financial terms were not disclosed. โ€œWe are incredibly enthusiastic about the compelling research that has led to the development of Warden Bioโ€™s pioneering gene โ€ฆSee details»

Gene therapy company Kriya buys fellow Triangle startup Warden โ€ฆ

Jan 10, 2022 RESEARCH TRIANGLE PARK - Warden Bio, a startup with ties to Duke University, has been bought by Kriya, a gene therapy company with operations in RTP and in โ€ฆSee details»

Glenn Warden - President % CEO - Warden BioAssociates - LinkedIn

President % CEO at Warden BioAssociates · Experience: Warden BioAssociates · Location: Salt Lake City · 157 connections on LinkedIn. View Glenn Wardenโ€™s profile on LinkedIn, a โ€ฆSee details»

wardenbio.com

Wardenbio.comSee details»

Kriya snaps up Warden Bio to expand pipeline | The Pharmaletter

Jan 8, 2022 Warden Bio was established with a goal of comprehensively addressing multiple GSDs without approved therapies based on pioneering gene therapy technologies originally โ€ฆSee details»

WARDEN BIOSCIENCE ASSN. LLC - Company Information โ€ฆ

Find useful insights on WARDEN BIOSCIENCE ASSN. LLCโ€™s company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at WARDEN โ€ฆSee details»

Home - Warden Biomedia

Apr 16, 2025 Innovation is at the heart of what we do and we lead the field in research and development of eco-friendly random filter media.See details»

Warden Bio | Insights

Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»

Warden Bio | CipherBio

Explore Warden Bio's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»

Research, Development & Innovation - Warden Biomedia

Investing in the future of sustainable filter media. The wastewater treatment sector is under continuing pressure from sustainability and NetZero targets including ever tightening discharge โ€ฆSee details»

Technologies - Warden Biomedia

Trickling Filter Upgrade trickling filters using random filter media with high surface area and high voidage. LEARN MORE SAF Innovative filter mediaSee details»

linkstock.net © 2022. All rights reserved